Goldman Sachs analyst Chris Shibutani lowered the price target on Pfizer (NYSE: PFE) to $32.00 (from $33.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE